Method for the diagnosis of Helicobacter pylori infection, and a diagnostic kit for performing the method
Abstract
The method for the diagnosis of Helicobacter pylori infection by the oral administration of defined amounts of 13 C-labeled urea and examination for 13 C content of blood samples removed at a defined time is effected by a) removing from 0.1 to 0.6 ml of capillary blood from the finger or ear lob of a patient or venous blood of a patient, in both cases with an empty stomach before the beginning of the test; b) administering an exact amount of from 10 to 50 mg of 13 C-urea in aqueous solution with a pH value of 2 to 4 to the patient; c) again removing capillary or venous blood exactly after 10 to 15 min from the administration; and d) determining the 13 C content of the blood samples by isotope ratio mass spectrometry (IRMS), and deducing the presence of Helicobacter pylori from the increase of the 13 C values.
Claims
exact text as granted — not AI-modified1 - 5 . (canceled)
6 . A kit for diagnosing Helicobacter pylori infection comprising:
a) an aqueous solution having a pH of 2 to 4 containing a dose of exactly 10 to 50 mg of 13 C-urea and a pharmacologically acceptable organic acid; b) a patient instruction sheet; and c) two sample vessels for receiving blood samples, the sample vessels being suitable for holding a strong, non-volatile acid.
7 . The diagnostic kit of claim 6 further comprising a strong, non-volatile acid in each of the two sample vessels.
8 . The diagnostic kit of claim 6 , wherein the organic acid is citric acid.
9 . The diagnostic kit of claim 7 , wherein the organic acid is citric acid.
10 . The diagnostic kit of claim 6 further comprising a blood sampling device.
11 . The diagnostic kit of claim 7 further comprising a blood sampling device.
12 . The diagnostic kit of claim 8 further comprising a blood sampling device.
13 . The diagnostic kit of claim 9 further comprising a blood sampling device.
14 . A kit for diagnosing Helicobacter pylori infection comprising:
a) a 1 st container holding 10 to 50 mg of 13 C-urea, b) a 2 nd container holding a solid, pharmacologically acceptable organic acid, d) a patient instruction sheet, and e) two sample vessels for receiving blood samples, the sample vessels being suitable for holding a strong, non-volatile acid.
15 . The diagnostic kit of claim 14 , further comprising a strong, non-volatile acid in each of the two sample vessels.
16 . The diagnostic kit of claim 14 , wherein the organic acid is citric acid.
17 . The diagnostic kit of claim 15 , wherein the organic acid is citric acid.
18 . The diagnostic kit of claim 14 , further comprising a blood sampling device.
19 . The diagnostic kit of claim 15 , further comprising a blood sampling device.
20 . The diagnostic kit of claim 16 , further comprising a blood sampling device.
21 . The diagnostic kit of claim 17 , further comprising a blood sampling device.Join the waitlist — get patent alerts
Track US2006133999A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.